Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 185-193 , May 2009

Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus

  • Vicki H.K. Tam

      Affiliations

    • Diabetes Centre, Department of Medicine and Geriatrics, Caritas Medical Centre, Hong Kong SAR, China
    • Corresponding Author InformationCorresponding author.
    • ,
  • Ellen P.K. Lam

      Affiliations

    • Diabetes Centre, Department of Medicine and Geriatrics, Caritas Medical Centre, Hong Kong SAR, China
    • ,
  • Benjamin C.Y. Chu

      Affiliations

    • Department of Ophthalmology, Caritas Medical Centre, Hong Kong SAR, China
    • ,
  • K.K. Tse

      Affiliations

    • Department of Ophthalmology, Caritas Medical Centre, Hong Kong SAR, China
    • ,
  • L.M. Fung

      Affiliations

    • Diabetes Centre, Department of Medicine and Geriatrics, Caritas Medical Centre, Hong Kong SAR, China

Received 21 August 2007 ,Accepted 24 March 2008.

References 

  1. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21:1071–1075
  2. American Diabetes Association . Position statement: Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S84–S87
  3. Arun CS, Pandit R, Taylor R. Long-term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: An observational study. Diabetologia. 2004;47:1380–1384
  4. Centers for Disease Control and Prevention . Blindness caused by diabetes—Massachusetts, 1987–1994. Morbility & Mortality Weekly Report. 1996;45:937–941
  5. Chan WB, Tong PC, Chow CC, So WY, Ng MC, Ma RC, et al. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabetic Medicine. 2004;21:349–353
  6. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998;351:28–31
  7. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY. Incidence and progression of diabetic retinopathy among non-insulin dependent diabetic subjects: A 4-year follow up. International Journal of Epidemiology. 1995;24:787–795
  8. Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Archives of Ophthalmology. 1996;114:1079–1084
  9. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Medical Journal. 2000;6:43–52
  10. Di Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164–176
  11. Diabetic Retinopathy Study Research Group. Report VII. A modification of the Airlie House Classification of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 1981;21:210–226
  12. Dimitrov PN, Mukesh BN, McCarty CA, Taylor HR. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clinical & Experimental Ophthalmology. 2003;31:397–402
  13. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. American Journal of Ophthalmology. 2004;137:675–682
  14. Janghorbani M, Jones RB, Murray KJ, Allison SP. Incidence of risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic Epidemiology. 2001;8:309–325
  15. Kim HK, Kim CH, Kim SW, Park JY, Hong SK, Yoon YH, et al. Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care. 1998;21:134–138
  16. Klein BE, Moss SE, Klein R, Surawicz TS. Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIII. Relationship of serum cholesterol to retinopathy and hard exudates. Ophthalmology. 1991;98:1261–1265
  17. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care. 2003;26:320–326
  18. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type 2 diabetic patients. BMC Ophthalmology. 2004;4:9
  19. Moss SE, Klein R, Klein BE. The association of alcohol consumption with the incidence and progression of diabetic retinopathy. Ophthalmology. 1994;10:962–968
  20. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy and cardiovascular disease in NIDDM. Diabetes Care. 1996;19:1243–1248
  21. Schrier RW, Estario RO, Jeffers B. Appropriate blood pressure control in NIDDM (ABCD) Trial. Diabetologia. 1996;39:1646–1654
  22. Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A, et al. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care. 2005;28:2806–2807
  23. Sjolie AK, Porta M, Parving HH, Bilous R, Klein R. The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: Baseline characteristics. Journal of the Renin–Angiotensin–Aldosterone System. 2005;6:25–32
  24. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Survey of Ophthalmology. 1998;42:535–547
  25. Srivastava BK, Rema M. Does hypertension play a role in diabetic retinopathy?. The Journal of the Association of Physicians of India. 2005;53:803–808
  26. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156–163
  27. Tam TK, Lau CM, Tsang LC, Ng KK, Ho KS, Lai TC. Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Medical Journal. 2005;11:438–444
  28. Early worsening of diabetic retinopathy in the Diabetic Control and Complications Trial. Archives of Ophthalmology. 1998;116:874–886
  29. UKPDS 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. British Medical Journal. 1998;317:703–713
  30. Wilkinson WJL. Angiotensin and diabetic retinopathy. The International Journal of Biochemistry & Cell Biology. 2006;38:752–765
  31. Young RJ, McCulloch DK, Prescott RJ, Clarke BF. Alcohol: Another risk factor for diabetic retinopathy?. British Medical Journal. 1984;288:1035–1037

PII: S1056-8727(08)00036-6

doi: 10.1016/j.jdiacomp.2008.03.001

Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 185-193 , May 2009

Article Tools

* Image Usage & Resolution